HS research update (2026-08-01): What’s new on PubMed?

Publication overview

This update includes 30 PubMed publications with abstracts from the monitoring window 2026-07-18 to 2026-08-01. The most common themes are biologicsBiologic: A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient.BiologicA class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient.Read more in the glossary, quality of life, pain, comorbiditiesComorbidity: An additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression.ComorbidityAn additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression.Read more in the glossary, wound care.

• Compared with the previous update: not automatically assessed.
• No guideline/NEJM/Lancet-style high-impact matches with abstracts in this window.
• This is a research overview, not a guideline update or medical recommendation.

Top highlights

The most useful signal this round is not a single treatment instruction. It is what researchers are looking at more closely: wound healing after procedures, possible new anti-inflammatory approaches, care quality, and comorbidities.

• Insurance disparities in hidradenitis suppurativa: A comprehensive review of demographics, outcomes, and access to care.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that disproportionately affects women, African Americans, and individuals of biracial descent. It is associated with substantial physical and psyc… What makes it notable here is that it approaches HS through wound care, quality of life, biologics, pain. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42522484)
• Patient Journey and Unmet Needs in Hidradenitis Suppurativa: Insights from an Italian Survey.: The abstract describes a survey-based report. In practical terms, it focuses on this question or finding: Background/Objectives: Hidradenitis suppurativa (HS), a chronic, inflammatory skin condition, severely affects quality of life. Despite advances in understanding its pathophysiology, major gaps persist in diagnosis an… What makes it notable here is that it approaches HS through quality of life, diagnostic delayDiagnostic Delay: The average time between first symptoms and a correct Acne Inversa diagnosis. Repeatedly measured at roughly 7 to 10 years in international studies. Reducing this delay is one of the single most important advocacy goals in the HS field.Diagnostic DelayThe average time between first symptoms and a correct Acne Inversa diagnosis. Repeatedly measured at roughly 7 to 10 years in international studies. Reducing this delay is one of the single most important advocacy goals in the HS field.Read more in the glossary, biologics. The main limitation to keep in mind is: Surveys can show practice patterns and opinions, but they do not by themselves show which approach works best for patients. (PMID 42513646)
• Illness Acceptance in Patients with Hidradenitis Suppurativa Depends on Disease Severity and Psychosocial Parameters: An Observational Cross-Sectional Study.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: Background/Objectives: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with substantial physical and psychosocial burden. Illness acceptance is an important component of adaptation to c… What makes it notable here is that it approaches HS through comorbidities, quality of life, pain. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42513543)
• Probable Association Between Hidradenitis Suppurativa and Inflammatory Bowel DiseaseInflammatory Bowel Disease (IBD): Crohn's disease and, less commonly, ulcerative colitis. Acne Inversa patients have a several-fold higher risk of IBD than the general population. If you have HS and unexplained chronic diarrhoea, weight loss, abdominal pain, or perianal disease, a gastroenterology referral is warranted.Inflammatory Bowel Disease (IBD)Crohn's disease and, less commonly, ulcerative colitis. Acne Inversa patients have a several-fold higher risk of IBD than the general population. If you have HS and unexplained chronic diarrhoea, weight loss, abdominal pain, or perianal disease, a gastroenterology referral is warranted.Read more in the glossary: A Case Report.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurrent painful nodulesNodule: A firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa.NoduleA firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa.Read more in the glossary, abscessesAbscess: An inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds.AbscessAn inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds.Read more in the glossary, and sinus tractsSinus Tract: A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III.Sinus TractA tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III.Read more in the glossary primarily affecting intertriginous areas, causing significant quality of li… What makes it notable here is that it approaches HS through comorbidities, quality of life, pain. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42502566)
• Effect of adalimumabAdalimumab: A biologic drug from the class of TNF-α inhibitors and the first medication officially approved for treating moderate-to-severe Acne Inversa. It is marketed under the brand name Humira® and as biosimilars.AdalimumabA biologic drug from the class of TNF-α inhibitors and the first medication officially approved for treating moderate-to-severe Acne Inversa. It is marketed under the brand name Humira® and as biosimilars.Read more in the glossary treatment on lesions and inflammatory factors in patients with moderate-severe hidradenitis suppurativa.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: OBJECTIVES: To investigate the efficacy and safety of adalimumab (ADA) in the treatment of hidradenitis suppurativa (HS). METHODS: A retrospective analysis was conducted on the clinical data of 50 patients with HS. What makes it notable here is that it approaches HS through quality of life, biologics, pain. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42491044)

Featured publication

The featured paper is Patient Journey and Unmet Needs in Hidradenitis Suppurativa: Insights from an Italian Survey. in Journal of clinical medicine (PMID 42513646). The abstract mainly says this: Background/Objectives: Hidradenitis suppurativa (HS), a chronic, inflammatory skin condition, severely affects quality of life. Despite advances in understanding its pathophysiology, major gaps persist in diagnosis an…

Why it stands out: it connects to the priority themes quality of life, diagnostic delay, biologics and shows what HS researchers are trying to clarify right now. For readers, it matters because it gives one concrete example of how the field is framing a practical question or possible mechanism. The main limitation is that Surveys can show practice patterns and opinions, but they do not by themselves show which approach works best for patients.

What this may mean for patients (carefully, no advice)

If you live with HS, research updates can help you make sense of what’s being studied — for example which outcomes (pain, quality of life) researchers measure, or which comorbidities are increasingly part of the conversation.

But even when a study sounds promising, it usually does not tell you what is right for you personally. Consider using new findings as questions for your next appointment (e.g., “What are realistic goals for me?” or “Which related conditions should we keep an eye on?”), not as instructions.

What we don’t know / limitations

• This update includes only PubMed items with an abstract (without an abstract, safe summarization is limited).
• Studies vary widely (design, populations, outcome measures).
• This update provides no treatment advice and cannot assess individual risk.

Important: decisions belong in clinician conversations

This article is an editorial overview and is not medically reviewed. If something here worries or interests you, use it as a conversation starter for your next appointment. Decisions should always be made with qualified healthcare professionals.

FAQ

Why are there only a few new publications here?

This format is deliberately strict: it includes only new PubMed items from the monitoring window that have an abstract and were not already covered in earlier posts.

Does a new paper mean my treatment should change?

No. A single publication can be useful to know about, but it is usually not enough to guide decisions for one specific person.

Why emphasize limitations so much?

Because abstracts show only part of the picture. Study design, patient population, endpoints, and follow-up all matter before results can be interpreted responsibly.

Sources & original papers

Each point below maps to an original source (PubMed link, plus DOI/PMCID when available).